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Preface 
Benzene is a well known xenobiotic environmental pollutant 
and is a natural constituent of crude oil. Emissions from 
burning coal and oil, benzene waste and storage operations, 
motor vehicle exhaust, evaporation from gasoline service 
stations and use of industrial solvents increase benzene level 
in the air. Since tobacco contains high level of benzene, 
tobacco smoke is another source of benzene in air. People 
living around hazardous waste sites, petroleum refining 
operations, petrochemical manufacturing sites, or gas station 
may be exposed to higher levels of benzene in air. 
Benzene causes disorders in the blood. People who breath 
benzene for long periods may experience harmful effects in the 
tissues that form blood cells, especially the bone marrow. 
These effects can disrupt normal blood production and cause a 
decrease in important blood components. A decrease in the 
number of functional red blood cells can lead to anemia. Long 
term exposures to high levels of benzene in the air can cause 
cancer of the tissues that forn^ . white blood cell leukeria) . 
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the cell to defend itself against the oxygen derived species 
resulting in oxidative injury. Benzene exposure has been shown 
to generate organic free radicals and superoxide radical and 
lead to accumulation of iron. 
In view of the protective role of antioxidants, it might 
be of interest to evaluate the antioxidant activities in serum 
after exposure of benzene to experimental animals (viz. uric 
acid, albumin, ascorbic acid, oC -tocopherol, ceruloplasmin, 
ferroxidase activity and catalase) and to evaluate the 
transition metal ion concentrations (viz. iron and copper) in 
liver and in isolated rat liver nuclei by atomic absorption 
spectrophotometery. In view of accumulation of £-aminolevulinic 
acid (ALA) and increased excretion of ALA in urine during 
benzene exposure it is worthwhile to study autooxidation of ALA 
and the ability of oxygen radicals thus produced has the 
capacity to degrade biomolecules. Also to investigate the 
effect of copper catalysed autooxidation of ALA to generate 
oxyradicals may have physiological significance because trace 
amounts of copper were detected in certain extracellular fluids. 
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Introduction 
Benzene 
Benzene is an aromatic hydrocarbon (CgHg) and is 
colourless liquid with a sweet odor. Due to high vapour 
pressure, benzene evaporates into air very quickly and is highly 
flammable. It is abundant in coal tar distillates and is a by 
product of coke and petroleum refining. Natural sources, which 
include volcanoes and forest fires, account for a small amount 
of benzene in the environment. Today benzene is commercially 
recovered from both coal and petroleum sources. Small 
quantities of benzene are also derived from coal in the light 
oil produced during coke manufacture (Greek, 1990) . 
Uses of Benzene :-
In the past benzene was widely used as a solvent, but this 
use is now decreasing due to its toxic nature. The T.ajor uses 
of benzene are ir th3 production of ethylbenzene, zimene and 
cyclohexane. Otner industrial use of rr.e benzene 13 in the 
production cf rutoer plastics, paints, adr.esives, nylrr. fibres, 
artificial leather and chemicals (such as maleic anhydride and 
aniline) (Eveleth, 1990). Benzene is also a component of 
gasoline since it occurs naturally in crude oil and since it is 
a by product of oil refining processes. Benzene is especially 
important for unleaded gasoline because of its anti-knock 
characteristics. For this reason, the concentration of 
aromatics such as benzene in unleaded fuels has increased (Brief 
et al., 1980). 
General Population and Occupational Exposure :-
Virtually all (99.9%) of the benzene released into the 
environment is emitted into the air. Inhalation is the dominant 
pathway of human exposure, accounting for more than 99% of the 
total daily intake of benzene (Hattemer-Frey et al., 1990). The 
general population is exposed to benzene mainly through 
inhalation of contaminated air particularly in areas of heavy 
motor traffic and around gas stations and through tobacco smoke 
from both active and passive smoke. Since benzene is a 
constituent of auto exhaust, people who spend more time in cars 
or in areas of heavy traffic will have increased personal 
exposure to benzene. Pumping gasoline can also be a significant 
source of exposure. A study reported a breathing - level 
benzene concentration of 1 ppm while pumping gas (Bond et al., 
1986) . 
Probably the most significant source of benzene exposure 
for the general population is active smoking of tobacco. 
Smoking accounts for about half of the total population burden 
of exposure to benzene (Wallace, 1989). All outdoor source. 
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including automobile exhaust and stationary source emissions, 
account for only about 20% of the total population exposure to 
benzene (Wallace, 1989) . 
Other source of inhalation exposure to benzene include air 
around hazardous waste sites, industrial facilities and 
emissions from consumer products (paints, adhesives, rubber 
products and tapes). 
Benzene metabolism :-
Benzene requires metabolism to induce its toxic effects 
and follows similar pathways in humans and animals. The 
metabolism of benzene occurs in bone marrow also, as well as in 
the liver and is metabolized by cytochrome P-450 dependent 
mixed-function oxidase enzymes. Metabolism of benzene is very 
complex (Figure- 1) and is primarily metabolized to phenol, 
catechol, hydroquinone, 1,2,4-benzenetriol, trans, trans-muconic 
acid and benzene dihydrodiol. The majority of these phenolic 
metabolites are excreted in urine as glucuronide and sulphate 
conjugates. In experiments with rabbits, accumulation of 
several polyphenolic metabolites of benzene have been observed 
in bone marrow against the concentration gradient (Greenlee et 
al., 1981). 
Initially benzene is metabolized to benzene oxide (Jerina 
et al., 1968), which is further metabolized by one of four 
pathways. The first metabolite is formed by rearrangement of 
the benzene oxide to phenol spontaneously. Phenol is either 
conjugated to glucuronide and sulphate directly or is oxidized 
to hydroquinone and followed by conjugation to hydroquinone 
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glucuronide or sulphate. The second pathway for benzene oxide 
metabolism consisted of reaction with glutathione and subsequent 
modification of the mercapturic acid (Henderson et al. , 1989). 
The third pathway for benzene metabolism involved in conversion 
of benzene oxide into benzene dihydrodiol by epoxide hydrase 
(Tunek et al. , 1981). Benzene dihydrodiol is converted into 
catechol by oxidation of benzene dihydrodiol by a soluble NADP"^ -
dependent enzyme, benzene dihydrodiol dehydrogenase (Ayengar et 
al., 1959) and finally conjugation to glucuronide and sulphate. 
Benzene dihydrodiol is also converted into 1,2,4-benzenetriol by 
some unknown mechanism, which is one of the potent toxic 
metabolite of benzene. The fourth pathway of benzene oxide 
metabolism consists of the ring opening reaction resulting in 
the formation of trans, trans-muconic acid. However the 
metabolic pathway of trans, trans-muconic acid in vivo is yet to 
be identified (Latriano et al., 1986). The corresponding 
dialdehyde, trans, trans-muconaldehyde has been shown to be a 
precursor of muconic acid in vivo (Witz et al., 1990). 
Benzene Toxicity :-
Benzene exposure leads to the development of bone marrow 
depression characterized by progressive leucopenia, anemia and 
pancytopenia (Snyder, 1987) . The responses to chronic benzene 
exposure have been classified as either bone marrow depression 
and aplastic anemia or the generation of acute myeloblastic 
leukemia (AMD and related forms of acute lymphocytic/ncn-
lymphocytic leukemia. Collectively, these abnorm.alities have 
been termed as preleukemic syndrome or myeicdysplasric syndrome 
(Bagby, 1986; Tricot, 1991) . Irons (1988) and Tricot (1991) 
suggested that the spectrum of bone marrow toxicities produced 
by exposure to benzene represented a form of myelodysplastic 
syndrome resulted in bone marrow depression and that might lead 
to fatal aplastic anemia. Anon (1982) reported that benzene is 
a human leukemogen. Chronic benzene poisoning exhibited a 
variety of changes in the number of basophils, eosinophils, 
lymphocytes, and other bone marrow function in workers (Aksoy et 
al., 1971). 
Goldstein et al., (1982) reported on the production of a 
limited number of myelogenous leukemias in rats and mice exposed 
to benzene by inhalation. The reports by Maltoni et al. (1989) 
and Huff et al., (1989) of benzene-induced carcinogenicity in 
rats and mice given benzene orally focussed on solid tumors and 
multiple carcinogenic foci. The zymbal gland was a primary 
carcinogenic site in both sexes of both species. Later studies 
using the inhalation route (Maltoni et al., 1989) also 
demonstrated the multipotential carcinogenic activity of 
benzene. Excluding the studies by Yin et al., (1987) there is 
no strong evidence for benzene-induced solid tumors of these 
types in human. Snyder et al., (1980) also reported the 
production of thymic lymphoma after inhalation of benzene in 
C57B1/6J mice but not in AKR mice. Farris et al., (1993) 
observed the malignant lymphoma along with preputial gland 
carcinomas and lung adenomas in CBA/Ca mice exposed to benzene 
through inhalation. Neither the Cronkite et al. , ;i989' r.cr the 
Farris et al., (1993) studies demonstrated acute granulccytic 
leukemia in benzene inhaled mice. 
Snyder and Chatterjee (1991) and Yardley-Jones (1991) have 
studied the pathway of benzene metabolism and the role of 
benzene metabolites in the production of benzene toxicity. 
Hepatic metabolism of benzene appears to be a critical step in 
the mechanism of benzene toxicity. Lee ez al. , (1981) reported 
that early erythroblasts are sensitive to benzene and its 
metabolites. Benzene has long been known to produce chromosomal 
abnormalities (Eastmond, 1993) and suggested that benzene may 
have caused chromosom.e breakages and rearrangements in a stem 
cell that proliferated, leading to erythroleukemia. Eastmond 
(1993) also observed that the quinone mietabolites of benzene can 
cause aneuploidy to chromosome nondisjunction and nonrandom 
chromosomal alteration in individuals with advanced forms of 
benzene-induced myelotoxicity. The association between 
chromosomal abnormalities and leukemia in benzene exposed rats 
has been reviewed by Le Beau and Larson (1991). Tice et al., 
(1980) exposed mice to benzene by inhalation and demonstrated an 
increased frequency of sister chromatid exchanges in bone marrow 
cells and suggested that benzene metabolites were responsible 
for these effects. Muconaldehyde, a hypothesized ring open 
benzene metabolite also produced sister chromatid exchanges in 
B6C3F1 mice (Witz et al., 1990). 
The highly electrophilic metabolites such as p-
benzoquinone and others are generated during benzene exposure in 
experimental animals and form covalently bound adducts with both 
nuclear and mitochondrial DN7A (Zastrcr.i 1?S3) . Kclacnar.a ez 
al., (1993) have demonstrated that benzene and its phenolic 
metabolites; phenol, hydroquinone and 1 I 4-benzenetrioi, induce 
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oxidative damage in the genome in the form of 8-
hydroxydeoxyguanosine in HL-50, promyelocytic leukemic cells and 
in the bone marrow of mice. Cheng et al. , (1992) demonstrated 
that benzene induced active oxygen radical production resulted 
in 8-hydroxydeoxyguanosine formation in vivo which may play a 
role in genotoxicity and leukemogenesis. Formation of 8-
hydroxydeoxyguanosine adduct is known to cause G-T and A-C base 
substitutions. 
Earlier reports have shown that benzene itself is probably 
not the actual toxicant, but is converted by hepatic metabolism 
to one or more metabolites and accumulated against the 
concentration gradient in bone marrow and exerts its toxic 
effects (Smith et al., 1989). Recent studies involve the 
polyphenolic metabolites as the toxic intermediates due to their 
capability to undergo autooxidation (Rao and Pandya. 1989). 
Myeloperoxidase (MPO) and eosinophil peroxidase (EPO) are the 
two principal enzymes in bone marrow which are responsible for 
the formation of quinone and semiquinone free radicals and 
activation of oxygen to superoxide radicals. These free radical 
metabolites of benzene with dioxygen and cellular targets such 
as DNA, GSH, protein and lipid are responsible for the benzene-
induced myelotoxicity and leukemia (Subrahmanyam et al., 1991a). 
Legathe et al., (1994) have demonstrated pharmacokinetic 
interaction between benzene metabolites, phenol and 
hydroquinone, in B6C3F1 mice. The consequence of which may be a 
higher o'jantity of 1,4-benzoquinone formation from hydroquinone. 
Many investigators have shown that benzer.e exposure interferes 
with iron metabolism and heme biosynthesis in experimental 
animals. These studies include decreased incorporation of ^Fe 
into circulating erythrocytes (Lee et al., 1974), inhibition of 
heme biosynthesis (Freedman et al., 1977; Rao and Pandya, 1980) 
and depletion of the regulatory heme pool (Siddiqui et al. , 
1988) . Existence of an intracellular pool of low molpcular 
weight iron compounds, maintaining a dynamic equilibrium between 
iron uptake, iron storage and iron incorporation into its final 
biochemical form have been described (Jacobs, 1977). Benzene 
administration led to accumulation of iron in bone marrow cells 
which can catalyse the formation of aldehydic products (base 
propenal) from DNA in presence of bleomycin (Rao et al., 1990). 
In all probability benzene alters heme metabolism of erythroid 
cells resulting in the increased internalization of iron 
transferrin-receptor complex and uptake of internalized iron is 
almost entirely restricted to erythroblasts. Recently in an in 
vitro study, Rao (1991) observed that hemin catalyzed the 
autooxidation of hydroquinone or 1,2,4-benzenetriol in the 
presence of reducing agent and resulted in the formation of 
aldehydic products from glutamate, deoxyuridine or DNA through 
the formation of reactive oxygen species. Hemin is essential 
for the erythroid differentiation process and accumulates in the 
immature red blood cells in nanomolar quantities as these cells 
differentiate (Lo et al., 1981). In immature red blod cells in 
bone marrow it has been noted that heme accumulates in the 
nucleus as these cells differentiate and nicking of nucelar DNA 
has been reported as it binds covalently to both protein and DNA 
(Mager and Bernstein, 1979; Lo et al., 1981). It has been 
postulated tr.at this action of hemin might account for its 
10 
influence in the differentiation of these and other cell types 
(Chen and London, 1981) . In view of the accumulation of 
polyphenolic metabolites after exposure to benzene and the 
presence of excessive amounts of heme in bone marrow cells offer 
an alternative mechanism for the bone marrow depressant effect 
of benzene (Rao, 1991). 
Antioxidants & its Importance :-
The formation of highly reactive oxygen containing 
molecular species is a normal consequence of a variety of 
essential biochemical reactions. Endogenous source of free 
radical formation include those that are generated and act 
intracellularly as well as those that are formed within the cell 
and are released into the surrounding area. Oxidases and 
electron transport systems are prime, continuous sources of 
intracellular reactive oxygenated free radicals. These reactive 
free radicals have capability to cause cellular damage (Machlin 
and Bendich, 1987). Exogenous sources of free radicals include 
certain pollutants (like benzene), smoke, hyperoxic environments 
and pesticides and are metabolized to free radical intermediate 
products that have been shown to cause oxidative damage to the 
target tissues (Halliwell and Gutteridge, 1985) . Thus aerobic 
cells are equipped with an array of antioxidant defences such as 
uric acid,_ albumin, oC^  -tocopherol, free -SH groups and 
ferroxidase activity which terminate the propagation of damage 
by free radicals. 
There are both enzymes and small molecular weignt 
molecules with antioxidant caoabilities that can protect acainst 
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the adverse effect of free radical reactions. Antioxidant is 
defined as any substance that when present at low concentration 
compared to those of an oxidizable substrate, significantly 
delays or inhibits oxidation of that substrate (Halliwell and 
Gutteridge, 1990) . Antioxidants could act against lipid 
peroxidation by decreasing localized O2 concentration and are 
preventing the initiation of peroxidation by scavenging species 
capable to abstract hydrogen atoms, such as hydroxyl radical 
('OH). Antioxidants are also capable of quenching or scavenging 
the singlet oxygen which can react directly with membrane lipids 
to produce peroxides. Lipid peroxidation is also scavenged by 
binding the antioxidants to metal ions in forms that will not 
generate reactive species and will not decompose lipid peroxides 
to peroxyl and alkoxyl radicals (Halliwell and Gutteridge, 
1990) . 
Antioxidants are following of two types :- (1) Enzymatic 
and (2) Non-enzymatic. Enzymatic antioxidants include 
superoxide dismutase (SOD), catalase and glutathione dependent 
systems. SOD scavenges the superoxide radicals and generate 
hydrogen peroxide (H2O2) which is less reactive than superoxide 
radical. Catalase is a heme protein, which catalyzes the 
reaction to convert H2O2 into water and O2. Glutathione 
dependent systems scavenge the hydroxyl radical on the expense 
of thiol group and play a vital defence against lipid 
peroxidation and are major interceptor of chemical 
mutagenesis/carcinogenesis (Chasseaud, 1979) . The in-.pcrtant 
non-enzymatic antioxidants are uric acid, albumin, oC -
tocopherol, ascorbic acid and ceruloplasnin. Uric acid has the 
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ability to scavenge oxidizing species such as singlet O2, HOCl 
and peroxyl radicals and inhibits lipid peroxidation. Uric acid 
can act as an antioxidant, both by binding iron and copper ions 
in forms that do not accelerate free radical reactions and by 
directly scavenging the free radicals (Ames et al. , 1981). 
Albumin can bind free Cu^ "*" ions and site directs any radical 
damage onto the albumin molecule itself and is powerful 
scavenger of HOCl transports bilirubin (Hartman and Shankel, 
1990) . oC -Tocopherol is most important lipid soluble chain 
breaking antioxidant and breaks chains by trapping peroxyl and 
alkoxyl radicals. Ascorbic acid has the ability to regenerate 
oC-tocopherol by reducing oC -tocopheryl radicals at the surface 
of membranes and is most important plasma antioxidant which 
scavenges water soluble peroxyl (RO2) radicals (Hartman and 
Shankel, 1990). Ceruloplasmin also inhibits lipid peroxidation 
stimulated by iron and copper ions and inhibits iron stimulated 
hydroxyl radical generation. It reacts slowly with superoxide 
and hydrogen peroxide. Ferroxidase activity does not result in 
formation of damaging oxygen radicals, unlike the non-enzymatic 
oxidation of Fe , which gives 'OH and other powerful oxidants 
(Halliwell and Gutteridge, 1990) . 
Review of Literature 
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Benzene is a known haeinatotoxic and leukemogenic agent 
(Snyder et al., 1977) and chronic exposure to concentrations 
ranging from 25 to 1000 ppm results in progressive degeneration 
of the haematopoietic system resulting in pancytopenia in 
experimental animals (Gerarde and Ahistrom, 1966). Occupational 
exposure to benzene has been associated with various blood 
dyscrasias and a variety of leukemia in humans (Rinsky et al., 
1987; Aksoy, 1989). 
Accumulating evidence indicate that the expression of 
benzene toxicity requires metabolism of the parent compound to 
one or more toxic species (Sammett et al., 1979). Several 
metabolites including phenol, catechol, hydroquinone, 1,2,4-
benzenetriol, trans, trans-muconic acid and benzene dihydrodiol 
have been identified in the urine of rabbits exposed to •^'^C 
benzene (Parke and Williams, 1953) . Inspite of the fact that 
the metabolism of benzene is extensively investigated and well 
understood, the intermediate agent(sj resDonsible for 
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haematotoxicity has not been identified. Moreover, the relation 
of benzene metabolism to leukemogenesis may very well differ 
from that usually observed in polycyclic aromatic hydrocarbon 
induced carcinogenesis. 
Many reports showed that benzene metabolism occurs in bone 
marrow also, as well as in the liver. Recent studies involve 
the polyphenolic metabolites as the toxic intermediates due to 
their capability to undergo autooxidation (Rao and Pandya, 
1989). Andrews et al., (1979) have shown the presence of 
cytochrome C reductase in bone marrow and demonstrated in vitro 
formation of hydroquinone, catechol and an unidentified 
metabolite in microsomes isolated from bone marrow incubated 
with benzene. Snyder et al., (1978) observed that benzene 
toxicity in mouse is associated with accumulation by bone marrow 
of labelled benzene and to a greater extent of its metabolites. 
Above evidences suggest that a reactive metabolite of benzene 
may be the ultimate haematotoxic agent. 
Polyphenolic metabolites of benzene- have been identified 
in rabbits exposed to benzene and accumulation of polyphenols in 
bone marrow against the concentration gradient has been reported 
(Irons, 1985). Metabolites of benzene have been reported to 
cause alterations in bone marrow (Morimoto and Wolff, 1980) and 
hydroquinone and 1,2,4-benzenetriol the two principal 
metabolites of benzene have been shown to be toxic and the 
suggested mechanisms include free radical formation via, 
superoxide and the cc"alent oirAmc of the semiquinones zc ^NA, 
RNA and other csllular macrcroiecules (Tunek ez al. , 153:,-
Irons, 1985). Involven"ent: cf ac::ive cxvcen radicals v,a^  sr.z;:z 
in the cytotoxic effect of polyphenolic metabolites of benzene 
besides the semiquinones which can bind to macromolecules (Rao 
and Pandya, 1989) . 
Quinone and semiquinone metabolites of polyphenols, 
through their capacity to react with nucleophilic groups of 
amino acids are reported to inactivate critical enzymes like DNA 
polymerase (Graham et al. , 1973), RNA polymerase II (Nagaraja 
and Shaw, 1982) and reverse transcriptase (Wick and Fitzgerald, 
1981) . Quinone or semiquinone metabolites of hydroquinone and 
1,2,4-benzenetriol have been shown to inhibit mRNA synthesis 
(Kalf et al., 1982), microtubule polymerization (Irons and 
Neptun, 1980), mitogen stimulation of lymphocyte growth (Weirda 
and Irons, 1982), effect macrophage function and activation 
(Lewis et al., 1988a) and form adducts with DNA (Jowa et al., 
1986). Autooxidation of polyphenolic compounds in presence of 
low concentrations of transition metal ion copper resulted in an 
increased production of active oxygen species which can release 
aldehydic products from glutamate or DNA (Rao and Pandya, 1989). 
Hydroquinone and catechol have been shown to be much more 
toxic to bone marrow cell cultures than benzene (Parmentier and 
Dustin, 1953). The covalent binding of hydroquinone and 
catechol in the bone marrow and subsequent potential pathways 
for the activation to benzoquinone and 1,2,4-benzenetriol which 
readily autooxidize to respective semiq^ jinone and/or quinones 
may play a significant role in the cytoccxicity of benzene. The 
quinone metabolites may arise from a aireci accivauion mechanism 
in bone marrow by superoxide radicals (Hansen et al., 1978) . 
16 
Considerable research has focused on the interaction of 
benzene and its metabolites with DNA. Initial studies by Lutz 
and Schlatter (1977) recovered radioactivity bound to rat liver 
DNA following the administration of tritiated and C-benzene to 
male rats. Additional studies by Gill and Ahmed (1981) and 
Arfellini et al., (1985) demonstrated that the benzene or 
metabolites were capable of binding to bone marrow DNA following 
in vivo administration. More recently, a series of 
investigations have focussed on the ability of the individual 
benzene metabolites to bind to deoxynucleotides and DNA in vitro 
(Rushmore et al., 1984; Jowa et al., 1986; Snyder et al., 1987; 
Bauer and Snyder, 1989; Latriano et al., 1989; Pongracz et al. , 
1990). These studies have indicated that 1,4-benzoquinone, 
hydroquinone, phenol, 1,2,4-benzenetriol, trans, trans-
muconaldehyde, catechol are all capable of forming adducts with 
deoxynucleotides and DNA during in vitro incubations. However, 
the nature of the binding in the bone marrow and the identity of 
the reactive species involved remain largely unknown. 
One consistent observation that has been made in benzene 
exposed humans and animals is the appearance of structural and 
numerical chromosomal aberrations and sister chromatid exchanges 
in lymphocytes and bone marrow cells indicating that benzene is 
genotoxic (Forni et al., 1971; Morimoto and Wolff, 1980; Tice et 
al., 1980; Dean, 1985; Yardley-Jones et al. , 1990). Chromosome 
and chromatid deletions, gaps, chromatid exchanges, 
hyperdiploidy and micronuclei induction, all have been detected 
to some extent. Since the induction of chromosomal aberrations 
in humans have been associated with a variety of neoplastic 
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development (Hecht and Hecht, 1987; Sandberg, 1987), these 
chromosomal aberrations could also contribute to the myelotoxic 
and leukemogenic effects of benzene in humans. Benzene exposure 
to experimental animals has been shown to inhibit ENA, RNA and 
protein synthesis (Falf, 1987; Cooper and Snyder, 1988). 
Benzene metabolites interfere with DNA replication and 
transcription in rat liver and bone marrow mitochondria in 
vitro, that has been attributed to the inhibicicn cf DNA 
polymerase gamma activity by hydroquinone and 1,4-benzoquinone. 
Studies by Lee et al. , (1988) have confirmed that an inhibition 
of DNA synthesis occurs in bone marrow following the in vivo 
administration of 1,2,4-benzenetriol to mice and have indicated 
that inhibition occurred at doses that had no inhibitory effect 
on the synthesis of protein or heme. These authors reported 
that benzene itself had the ability to inhibit DNA synthesis in 
vitro in cell free incubations following the addition of 
benzene. 
Previous studies have suggested the involvement: of iron or 
copper in benzene metabolite induced DNA damage through a 
mechanism involving the generation of reactive oxygen species 
(Lewis et al., 1988b; Rao and Pandya, 1989; Kawanishi et al. , 
1989). In vitro studies by Rahman et al., (1989) and Ahmad et 
al., (1992) have shown that naturally occurring flavonoid, 
quercetin, in the presence of Cu(II) and molecular oxygen caused 
breakage of calf thymus DNA, supercoiled pBR 322 plasmid ENA and 
single stranded M13 phage DNA. Copper is distribuned throughout 
the body with the liver and bone marrov; being rwc -ra^ or copper 
storage organs (Goyer, 1986; Linder, 1991). Copper has been 
identified as the essential redox-active centre in a variety of 
metalloproteins such as ceruloplasmin, Cu-Zn SOD, cytochrome 
oxidase, dopamine E-hydroxylase, tyrosinase, lysyloxidase and 
ascorbate oxidase (Linder, 1991). Since copper also exists in 
the nucleus and is closely associated with chromosomes and DNA 
(particularly Guanine) the chemical-metal redox system might be 
responsible for strand breaks in vivo during benzene exposure. 
In vitro, am.ong hydroquinone, 1,2,4-benzenetriol, catechol and 
phenol; hydroquinone/Cu and 1,2,4-benzenetriol/Cu were the 
two efficient DNA cleaving systems (Li and Trush, 1993a). 
Recently it was observed that Cu(II) strongly induces the 
oxidation of hydroquinone as such may be factor involved in the 
oxidative action and toxic to primary bone marrow stromal cells 
of DBA/2J mice (Li and Trush, 1993b). They further observed that 
Cu(II) is capable of directly reacting with hydroquinone, 
causing the one electron oxidation of hydroquinone to 
semiquinone radical (SQ') and reactive oxygen species generated 
in chemical metal redox system were responsible for in vitro 
plasmid DNA damage (Li et al. , 1995). The oxidative activation 
of hydroquinone to the electrophilic 1,4-ben2oquinone through a 
peroxidase/H202 system has been suggested to play an important 
role in the hydroquinone-induced bone marrow target cell injury 
(Smith et al., 1989). 
It is generally accepted that benzene produces bone narrow 
toxicity resulting in pancytopenia in man and l^czr:z.zorY ar.iTials 
and at least in man results in aplastic anemia and acute 
myeloblastic leukemia (Kalf, 1987). Earlier studies showed that 
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benzene inhibits heme biosynthesis at the level cf £ -
aminolevulinic acid (ALA) dehydratase (Rao and Pandya, 19S0) to 
result in ALA accumulation and its loss in urine (Rao ez al. , 
1919); depletes the regulatory heme content (Siddiqui ez al., 
1988), leading to accumulation of iron .Pandya et al. , 1590). 
Majority of intracellular iron is stored within the central core 
of ferritin, a large multisubunit protein found predominantly in 
the liver, spleen and bone marrow (Harrison, 1977. . The 
concentration of free or low molecular weight for~3 are 
negligible or non existent within the normal cells Rcmslo, 
1983). However, superoxide dependent reduccive release cf iron 
from ferritin may increase the low molecular weight ircn pool 
capable of undergoing redox reactions leading to the fcrniation 
of other toxic oxidant radicals. Existense of intracellular 
pool of low molecular weight iron compounds maintaining a 
dynamic equilibrium between iron uptake, iron storage and iron 
incorporation into its final biochemical form have been 
described (Jacobs, 1977). Many studies have shown that 
inhibition of iron uptake and heme biosynthesis are the 
causative factors of benzene induced aplastic anemia L^ee et 
al., 1974). In all probability benzene alters heme me-abolism 
in erythroid cells resulting in the increased internalizarion of 
iron transferrin receptor complex. Benzene may also likely 
affect by an unknown mechanism, the utilization of internalized 
iron, the uptake of which is almost entirely restricted to 
erythrcblasts (laccpetta and Morgan, 15=3) resulting ^n the 
accumulation of low molecular weight ircn components. 
Aims and Objectives 
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A large number of xenobiotics including environmental 
agents and therapeutic formulations exert their toxic effects 
via radicals which react readily with lipids, nucleic acids, 
carbohydrates and proteins and inhibit sulphahydryl dependent 
enzymes of the intermediary metabolism. Hydroxy metabolites of 
benzene such as hydroquinone and 1,2,4-benzenetriol are 
intermediate products of benzene metabolism. These compounds 
have been shown to be toxic by the mechanism include free 
radical formation via superoxide and covalent binding of the 
semiquinones to DNA, RNA and other cellular macromolecules. 
Active oxygen species capable of initiating lipid peroxidation 
and other deleterious oxidative processes are generally proposed 
to result from reactions between oxygen radical and transition 
metals. Xenobiotics that lower cellular antioxidants, both 
enzynatically and nonenzymatically cause cell injury due to 
facilitated attacK on essential cell constituents. This leads 
to oxidative stress which has been defined as the inacilitv cf 
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Exposure to benzene requires metabolism to induce its 
toxic effects and follows similar pathways in humans and 
animals. Inside the body, the metabolites of benzene are 
responsible in the formation of reactive oxygen species which 
may play a role in benzene induced toxicity. To over come the 
toxic effect, the mammalian cells are equipped with an array of 
antioxidant defences. During our study the antioxidants level 
in serum and liver were evaluated in benzene exposed 
experimental rats and this study may provide the clinical and 
therapeutic information on biochemical and haematological effect 
of benzene. 
Materials and Methods 
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Chemicals : -
Benzene of high purity was obtained from Glaxo 
Laboratories India (ANLAR). Bathophenanthroline sulfonic acid, 
catalase (bovine liver, 2,000-5,000 units/mg protein), 
superoxide dismutase (bovine erythrocytes, 2,500-5,000 units/mg 
protein), bovine serum albumin, L-glutamate monosodium, S -
aminolevulinic acid, 2-deoxyuridine, oC-tocopherol ^nd dithio-2-
nitrobenzoic acid were obtained from Sigma Chemical Company, St. 
Louis, U.S.A. Folin-Ciocalteu's phenol reagent, tris-
hydroxymethyl amino methane, glutathione and trichloroacetic 
acid were obtained from Sisco Laboratories, India. 2-
Thiobarbituric acid was obtained from BDH chemicals Limited, 
England. All other chemicals were either obtained from C.S.I.R. 
Centre for Biochemicals, New Delhi, India or were of analytical 
grade. 
IncrruiTients :-
Spectronic 21, Bausch and LcrJD, Clark elecnrode assembly 
or. a Gilson Medical Electronic Cxygraph, Ultra-turrax T25 
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n o m o g e n x z e x , >iiuxnL:u-Duwiuciii optso-ux opxiuLUi. xaiuiut; Lex , A t o m i c 
absorption spectrophotometer, Mettler balance, Dig i ta l pH meter 
and Centrifuge (REMI) were the major instruments used in t h i s 
study. 
Animals :-
Albino rats of either sex (Swiss wistar strain, 100-110 
gra) bred at the animal house unit of I.T.R.C. were divided into 
six separate groups (three groups male and three groups female) 
of six animal each. One group from each sex received benzene 
(0.5 ml/kg body weight) intraperitoneally and another group from 
each sex received benzene (1.0 ml/kg body weight) subcutaneously 
daily for ten days. After the termination of the treatment, 
blood was collected into clean tubes from jugular vein and kept 
at 4°C. Control and experimental rats were sacrificed by 
cervical dislocation and liver and brain were immediately 
excised and 10% liver homogenate was prepared in 0.15 M KCl to 
study lipid peroxidation. Liver homogenate was also made in 
0.02 M ethylenediamine tetraacetic acid (EDTA) for the 
estimation of sulphahydryl content, ascorbic acid, oC-tocopherol 
and catalase activity. Brain homogenate 2% was also made in 
0.15 M KCl for studying ferroxidase activity. 
Protein Estimation :-
Protein in different tissues was estimated by the method 
of Lowry et al., (1957). Tissue homogenate was precipitated 
with trichloroacetic acid (TCA). The precipitated protein was 
centrifuged and the protein pellet was dissolved in IN NaOH. 
Finally suitable an-.cunt of NaOH dissolved protein was diluted to 
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1.0 ml with distilled water and 5.0 ml of alkaline copper 
reagent was added. After 10 minutes, 0.5 ml of Folin-Ciocalteu 
reagent was added. Absorbance was read at 750 nm after 20 
minutes. Bovine serum albumin (BSA) was used as standard. 
Uric Acid Estimation :-
Serum uric acid was estimated by the method of 
Wootton (1964). Suitable amount of serum, 0.2 ml was diluted 
upto 2.0 ml with distilled water and 0.325 ml of 0.66 N H2SO4 
and 0.325 ml of 10% sodium tungstate were added. The contents 
were kept for 10 minutes at room temperature and centrifuged at 
3000 rpm for 15 minutes. Finally 1.0 ml of supernatant was 
taken in another tube, to which 1.0 ml of 14% sodium carbonate 
and 1.0 ml of uric acid reagent were added. Mixed well and 
absorbance was taken after 15 minutes at 680 nm. For standard 
plot, uric acid (0-40 ug) was diluted upto 1.0 ml with water, to 
which 1.0 ml of 14% sodium carbonate and 1.0 ml of uric acid 
reagent were added. Using this standard plot uric acid in serum 
was calculated in terms of mg/100 ml serum. To prepare the uric 
acid reagent, 10 gms of sodium tungstate and 1.0 gm of Na2HP0^ 
anhydrous was dissolved in 30 ml of distilled water. In a 
second flask 2.5 ml of cone. H2SO4 was added to 10 ml water and 
the diluted H2S0^ solution was added to the tungstate phosphate 
solution and this mixture was reflexed for one hour. The 
contents were diluted to 100 ml with distilled water. 
Serum Albumin Estimation :-
Serum albumin was estimated by the method of Debro at al., 
(1557). 0.1 ml of serum was diluted to 2.0 ml with alcoholic -
TCA (1% TCA in 96% alcohol), mixed well by inversion and 
centrifuged to sediment the precipitated globulin. Finally 0.1 
ml of the supernatant was taken for Folin-Ciocalteu reagent (by 
Lowry method). Albumin concentration was calculated from the 
standard plot of bovine serum albumin. 
Sulphahydryl Estimation :-
Total and free sulphahydryl (glutathione) were estimated 
using the standard procedure described by Sedlak and Lindsay 
(1968) . 
(i) Total Sulphahydryl Estimation :- Liver homogenate in 0.02M 
EDTA (0.5 ml of 2.5%) was mixed with 0.2M tris buffer (pH 8.2), 
0.1 ml of dithio-2-nitrobenzoic acid (DTNB) (99 mg/25 ml 
absolute methanol) and 7.9 ml of absolute methanol and kept at 
room temperature for 15 minutes. After centrifugation at 3000 
rpm for 15 minutes, absorbance of the supernatant was read at 
412 nm. 
(ii) Free Sulphahydryl Estimation :- To 1.0 ml of 2.5% liver 
homogenate (in 0.02M EDTA) was added 1.0 ml of 10% TCA. The 
test tubes were shaken intermittantly for 15 minutes at room 
temperature and centrifuged at 3000 rpm for 15 minutes. 
Supernatant (1.0 ml) was mixed with 1.4 ml of 0.4 M tris buffer 
(pH 8.9). Finally 0.1 ml of DTNB was added and mixed well. The 
absorbance was read at 412 nm. 
Sulphahydryl content was calculated from the standard plot 
of cysteine prepared in the same manner and expressed in terrs 
of p, moles/gm liver. 
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cC-Tocopherol Estimation :-
oC-Tocopherol was measured both in liver homogenate and 
serum by the method of Taylor et al., (1976). Liver homogenate 
(1.5 ml of 10%) in 0.02 M EDTA was used in reaction mixutre. 
Reaction mixture contained 1.0 ml of 23% ascorbic acid, 2.0 ml 
of absolute ethanol, 1.5 ml of 10% of liver homogenate and 1.5 
ml of tris-maleate buffer (50 mM, pH 6.5). Reaction mixture was 
incubated at 70°C for 5 minutes. After that 2.0 ml of 10 N KOH 
was added and incubated for 30 minutes at 70°C. Finally cC. -
tocopherol was extracted in 4.0 ml of n-hexane by mixing for 1 
minute on a vortex mixer and then centrifuged for 5 minutes at 
2000 rpm. Portion of hexane phase was removed for fluorometric 
measurement at 286 nm excitation and 330 nm emission. 
Before fluorometric measurement it is necessary to remove 
the vitamin A interference. For this the hexane phase was 
pipetted into the test tube and 0.6 ml of 60% H2SO. was added. 
Samples were mixed vigorously for 30 seconds with a vortex mixer 
and after centrifugation the fluorescence of hexane phase was 
measured. 
External standard was prepared by addition of 1.0 ml of 
absolute ethanol that contained 2.5 ug oC-tocopherol to the 1.5 
ml water and 0.5 ml of 25% ascorbic acid mixture. Tocopherol 
concentration was calculated by comparing the sample 
fluorescence intensity with that of the external standard after 
correction had been made for the fluorescence intensity of the 
blank. Tocopherol recoveries were estimated from internal 
standard of 2.5 }xg tocopherol added to 1.5 ml of subcellular 
suspension. 
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Similarly, oC-tocopherol was also estimated in serum. An 
aliquot of 0.2 ml of serum was saponified with 1.0 ml of 10 N 
KOH at 70°C for 3 0 minutes and finally oC -tocopherol was 
extracted in 4.0 ml of n-hexane. .-.csorbance of hexane phase was 
taken at 286 nm excitation and 330 nm emission. 
Ascorbic Acid Estimation :-
Ascorbic acid in liver horr.cgenate was measured by the 
method of Schaffert and George (1955). Liver homogenate (0.5 ml 
of 10%) in 0.02 M EDTA was added in 4.5 ml of 6% TCA, mixed 
well and kept for 5 minutes at room temperature. After that 
tubes were centrifuged for 15 minutes at 3000 rpm. Supernatant 
was collected in separate tube to which activated charcoal was 
added and filtered. To 1.0 ml of filtrate in another tube, 3.0 
ml of 4% TCA and one drop of thiourea were added. After 
thorough mixing of the contents, 1.0 ml of 2,4-dinitrophenyl 
hydrazine was added. The tubes were boiled for 10 minutes on 
water bath and placed in crushed ice. Finally 5.0 ml of 85% of 
H2S0^, was added and absorbance was read at 515 nm after 10 
minutes. Sample blank was prepared in absence of filtrate. L-
ascorbic acid (0-60 p.g) in 4% TCA was used as standard. 
Ceruloplasmin Assay :-
Ceruloplasmin was assayed by the method of Herbert and 
Ravin (1961). Substrate, p-phenylenediamine-dihydrochloride 
(PPD-2HC1) was dissolved in a minir.um volume of hot distilled 
water, iacolorized with charccal, filtered while hot and 
recrystallized from the water clear filtrate. The white 
crystals of purified PFD-2HC1 were iried and stored in a vacuum 
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over caiciutii cl)ioride. A U.5% soiuLion oi tlie puiilied 
substrate was prepared in distilled water just prior to use in 
the test. 
Serum (0.1 ml) was blown into the bottom of the test 
tubes. Sodium azide (1.0 ml of 0.5%) was then added to one tube 
to provide as enzyme inhibited control. Sodium acetate buffer, 
8.0 ml (0.4 M, pH 5.5) was added to all the tubes, followed by 
1.0 ml of 0.5% solution of substrate. The test tubes were 
shaken to ensure thorough mixing and placed in water bath at 
37°C. After 1 hour of incubation, 1.0 ml of 0.5% sodium azide 
was added to each tube, excluding the control tube. The tubes 
were shaken once more to ensure thorough mixing and were placed 
in a refrigerator for 30 minutes at 4-10°C. The optical density 
of the cooled reaction mixture was taken at 530 nm. Results 
were expressed in terms of mg% ceruloplasmin in whole serum. 
Ferroxidase Activity Assay :-
Ferroxidase activity in serum was assayed as described by 
Gutteridge (1987) in the total reaction volume of 4 ml using 2% 
rat brain homogenate in 0.15 M KCl as a source of phospholipid. 
The reaction mixture for measuring ferroxidase activity 
contained, 3.0 ml 2% rat brain homogenate (w/v) , 20 ;uM Fe'^ '^  (as 
ferrous sulphate) and 1.0 ml of serum. Total reaction mixture 
was incubated for one hour at 37°C in a metabolic shaker. 
Reaction was stopped by adding 1.0 ml of 20% TCA. Supernatant 
was separated by centrifugation at 3000 rpm for 10 minutes. To 
2.0 ml aliquot was added 1.0 ml of 0.67% (w/v) 2-thiobarbituric 
acid (TBA) and TBA chromogen colour was developed by boiling the 
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tubes on water bath for 15 minutes. Optical density was 
measured at 532 nm. The values are expressed as nmoles of 
malonaldehyde equivalents generated by using molecular 
absorption coefficient as 1.56 x 10 cm" M'-*-. 
Catalase Assay :-
Catalase activity in liver homogenate was assayed by the 
method of Luck (1974). Liver (1.0 gm) was homogenized in 18.0 
ml of distilled water and to it 1.0 ml of 10% • deoxycholic acid 
(DOC) was added. The homogenate was kept at room temperature 
for 30 minutes. The homogenate was centrifuged at 35,000 rpm in 
the fixed angle 50 rotor for one hour and the supernatant was 
saved for catalase assay. 
For catalase assay, in reference cuvette, 3.0 ml of H/15 
phosphate buffer of pH 7.0 was taken and in the sample cuvette, 
3.0 ml of hydrogen peroxide (H2O2) buffer was added. An aliquot 
of 0.02 ml of supernatant of liver homogenate was added in 
reference and sample cuvette and mixed well with the 
micropipette and the time for the decrease in optical density 
from 0.450 to 0.400 at 240 nm was quickly measured. Catalase 
activity was calculated in terms of p, moles ^0^2 ^sduced per 
minute per mg protein using extinction coefficient 0.036 ^ mole~ 
cm'-'-L"-^  at 240 nm. 
Estimation of Serum Iron-Binding Capacity :-
Serum iron binding capacity was estimated by the method of 
Peters et al., (1956). To 0,2 ml of serum in the test tube 0.05 
ml ferrous sulphate solution (equals 11.2 mg of iron/ml) was 
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added and allowed to stand for 15 minutes at room temperature. 
After that 0.2 ml equivalent of the dry resin (Amberlite IRA 4]0 
resin) was added and stirred occasionally for 5 minutes. Then 
2.0 ml of 0.04M veronol buffer of pH 7,5 was added and continued 
to stir for 5 minutes. The contents were centrifuged briefly 
and 1.0 ml of the supernatant was taken using a manual pipette 
control to avoid disturbing the resin. To 1,0 ml of above 
supernatant, 1.0 ml of concentrated hydrochloric acid and 1.0 ml 
of B-mercaptoethanol were added. The reaction mixture was kept 
for 3 0 minutes at room temperature and precipitated with 1.0 ml 
of 30% TCA. After 20 minutes the tubes were centrifuged at 3000 
rpm for 10 minutes. After that 1,0 ml of supernatant was 
removed and 0.45 ml of saturated sodium acetate was added. 
Finally the colour was developed by adding 1.0 ml of 
bathophenanthroline sulfonic acid solution (20 mg 
bathophenanthroline sulfonic acid in 100 ml of isopropyl: 
isoamyl alcohol) (3:1). Absorbance was taken after 10 minutes 
at 535 nm. Blank tube contained 1.0 ml of distilled water, 0.45 
ml saturated sodium acetate and 1.0 ml of bathophenanthroline 
sulfonic acid solution. Standard iron tube contained, 0.5 ml of 
ImM Fe solution, 0,45 ml of saturated sodium acetate, 1.0 ml 
of bathophenanthroline sulfonic acid and diluted it upto 2.45 ml 
with distilled water. 
Estimation of Lipid Peroxidation :-
Lipid peroxidation was estimated in 10% liver homogenate 
by the method described by Bernheim et al., (1948). Liver 
homogenate (10%) was prepared in 0,15 M KCl, Liver homogenate 
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(10 ml) was taken in 25 ml conical flask and placed in metabolic 
shaker water bath at 37°C. An aliquot of 1,0 ml of homogenate 
was taken out at different time interval (i.e. 0, 30 and 60 
minutes) and precipitated with 1.0 ml of 10% TCA. After waiting 
for few minutes the tubes were centrifuged at 3000 rpm for 15 
minutes. Finally 1.0 ml of aliquot was taken out and 1.0 ml of 
0.6 7% (w/v) TBA was added. TBA chromogen colour was developed 
by boiling the tubes on water bath for 15 minutes and absorbance 
was read at 532 nm. Lipid peroxidation was expressed in terms 
of nmoles/hr/gm liver using molar extinction coefficient 
1.56x10^ cm'^M'^ at 532 nm. 
Formation of Thiobarbituric Acid Reactive Product (TEAR) from 
Glutamate or Deoxyuridine :-
Formation of TEAR from glutamate or deoxyuridine in the 
presence of 6 -aminolevulinic acid (ALA) with or without the 
addition of copper ions was followed according to the method 
described (Gutteridge, 1981; Quinlan and Gutteridge, 1987) . ALA 
(0.2-1.0 mM) and copper ions (0.002-0.16 mM) were used as the 
effective concentration to exhibit a linear progress of the 
reaction for upto 2 hrs. Thus, all experiments noted in the 
present studies were performed using 1.0 mM ALA, 0.16 mM copper 
ions and 2 hrs. incubation except otherwise indicated. The 
reaction mixture in a total volume of 1.2 ml contained 0.033 M 
sodium phosphate buffer in 0.15 M NaCl (pH 7.4), 4 mM glutamate 
or 3.2 mM deoxyuridine, 1.0 mM ALA and oxyradical scavengers. 
The reaction was initiated by the addition of CuSO^.5H2O to 
provide a final concentration of 0.16 mM copper ion. The 
contents were incubated for 2 hrs. at 37°C and the reaction was 
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terminated by the addition of 1.0 ml of 0.67% TBA (w/v) plus 0. "5 
ml of 10% TCA (w/v). The contents were heated for L5 minuLea in 
a boiling water bath and the resultant TBA chromogen was read at 
532 nm using Spectronic 21 spectrophotometer. The values are 
expressed as nmoles of malonaldehyde equivalents generated in 2 
hrs. by using E532 = 1.56 x 10^ cm'-'-M"-^ . 
Estimation of ALA :-
At the end of 2 hrs., incubation in the complete reaction 
mixture ALA was estimated by the method of Mauzerall and Granick 
(1956). The complete reaction mixture in a total volume of 1.2 
ml contained 0.033 mM of sodium phosphate buffer in 0.15 M NaCl 
(pH 7.4), 33 mM dimethyl sulfoxide and the reaction was 
initiated by the addition of 0.16 mM copper ion. ALA was 
estimated in 0.1 ml aliquot from the complete reaction mixture 
by condensation with acetylacetone to form a pyrrole in a knorr 
type reaction. Pyrrole was estimated by reaction with modified 
Ehrlich's reagent and measurement of resultant colour at 555 nm 
in Spectronic 21 spectrophotometer. A standard curve of ALA was 
also run in the concentration range of 15-75 nmoles and the 
values are expressed as nmoles of ALA utilized per 2 hrs. 
Oxygen Uptake :-
Oxygen uptake in the complete reaction mixture was 
followed with Clark electrode assembly on a Gilson Medical 
Electronic Oxygraph. Percent oxygen consumption was estimated 
in the reaction mixture containing 0.033 mM of phosphate buffer 
in 0.15 M NaCl (pH 7.4), 4.0 mM glutamate and ALA (0.5 and 1.0 
mM) . The reaction was initiated by the addition of 0.16 mM 
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copper ion. The means of at least two experiments are shown in 
variation of 10% or less of the average. 
Detection of Hydroxyl Radical :-
Hydroxyl radical ('OH) formation in the complete reaction 
mixture during autooxidation of ALA was detected by the 
formation of formaldehyde from dimethylsulfoxide (Klein et al. , 
1981). Incubation mixture of total volume (1.2 ml) contained 
0.033 M sodium phosphate buffer in 0.15 M NaCl (pH 7.4), 33 mM 
dimethyl sulfoxide and the reaction was initiated by the 
addition of 0.16 mM copper ion. After two hr of incubation 
formaldehyde formed from dimethyl sulfoxide was estimated by the 
method of Nash (1953). Formaldehyde formed was demonstrated by 
the addition of 2.0 ml of Nash reagent (Ammonium acetate, 3 0 
gms; acetylacetone, 0.4 gm; acetic acid 0.6 ml and water to make 
up 100 ml) . After thorough mixing the contents were heated at 
60°C for 30 minutes. The optical density was read at 415 nm. 
The amount of formaldehyde formed was calculated from the 
standard curve of formaldehyde which was run simultaneously. 
Metal Analysis :-
Metals were analyzed in liver tissue of male and female 
rats of benzene exposed and control group by the method 
described by Herman (1980) . Equal weight of liver tissue was 
added into the digestion flask containing 20 ml of digestion 
mixture (1:6:: Perchloric acid (60^): nitric acid). The flasks 
were boiled in the fuming chamber on hot plate till dry. The 
dry ash was dissolved in 5.0 ml of 0.1 N nitric acid and 
transfered into the test tube. The contents of iron and copper 
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were read using atomic absorption spectrophotometer. Results 
were expressed in terms of p^g metal/gm liver. 
S -ALA dehydratase Assay :-
6 -Aminolevulinic acid dehydratase activity was measured in 
liver homogenate by the method of Gibson et al., (1955). The 
enzyme activity was determined by measuring the amount of 
porphobilinogen (PBG) formed after 1 hr at 37°C in 3.0 ml 
reaction mixture containing 1.0 ml of 0.IM of. phosphate buffer 
(pH 6.8), 10 ;amoles of 6 -ALA-HCl substrate neutralized with 
buffer, 15 u moles of B-mercaptoethanol (0.33 ml/100 ml), 15 u 
moles of KCl and 0.5 ml of 10% liver homogenate in 0.15 M KCl 
(as enzyme source). Reaction was stopped by 1.0 ml of 20% TCA 
containing 0.1 M mercuric chloride. In'control tube substrate 
was added after adding TCA. To a measured aliquot, an equal 
volume of freshly prepared Ehrlich's reagent was added and 
optical density was measured at 555 nm using Spectronic 21 
spectrophotometer. Results were calculated in- terms of nmoles 
of PBG formed/hr/gm liver weight using molar extinction 
coefficient 6.2 x 10 cm" M~ . To prepare Ehrlich's reagent 1 
gm p-dimethylaminobenzaldehyde was dissolved in 30 ml of glacial 
acetic acid and 16 ml of 70% perchloric acid and diluted it to 
50 ml with glacial acetic acid. 
Results 
35 
The level of antioxidant potentials of serum of rats 
exposed to benzene by i.p. or s.c. are given in Table-1. Serum 
uric acid level was found to be significantly decreased and the 
maximum decrease of 52% was observed in the male group that 
received benzene intraperitoneally. Serum albumin concentration 
also ohowed decrease in male and female groups of rats exposed 
to benzene. The extent of decrease is more significant in 
female rats than in male rats. 
The free sulphahydryl content and lipid peroxidation in 
control and benzene exposed rats is given in Table-2. The free 
sulphahydryl content of liver showed significant decrease 
(P<0.05 in female; P <0.01 in male) in the groups which received 
benzene intraperitoneally. However, the group which received 
benzene s.c. did not show any significant decrease. Rate of 
lipid peroxidation showed marked increase (2-4 fold) in all the 
experimental groups when compared to respective control group of 
animals. 
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Ceruloplasmin levels in serum, ascorbic acid level in 
liver and catalase activity in liver (Table-3), and dC -
tocopherol levels in serum and liver (Table-4) did not show any-
significant change in any experimental group in comparison to 
the respective control group of rats. 8 -Aminolevulinic acid 
(ALA) dehydratase activity did not show any significant 
alteration in liver of experimental group of male rats compared 
tc the control group (Table - 5) . Earlier studies related to 
alteration in iron metabolism and benzene exposure were done 
only in female rats. In that context, ferroxidase activity and 
iron binding capacity were studied in only female rats. Both 
the groups that received benzene i.p. or s.c. showed that the 
protection offered by serum was less against Fe catalysed 
lipid peroxidation of brain homogenate than the serum from the 
control group of animals (Table-6). Serum iron concentration 
and total iron binding capacity was measured, which did not show 
any significant change in benzene exposed animals with respect 
to control group. Transferrin iron saturation in benzene 
exposed rats showed values comparable with the control group. 
Total iron and copper contents were estimated in liver 
tissue of male and female rats exposed to benzene 
intraperitoneally (Table-7). Only iron content showed 
significant increase in male and female rats (P<0.02; P<0.05) 
which received benzene i.p. and no significant change in copper 
content was observed in either sex. Also iron and copper 
contents were analyzed in isolated rat liver nuclei of benzene 
exposed female rats (i.p.). In isolated rat liver nuclei only 
iron content showed significant increase (P<0.05) but no change 
39 
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v\?as observed in copper content in isolated rat liver nuclei 
compared to the respective control group. 
TEAR formation from glutamate or deoxyuridine was observed 
only in the presence of both 6 -aminolevulinic acid (ALA) and 
copper ions which constitute the complete reaction mixture 
(Table-8) . Absence of either ALA or copper ions did not show 
any TEAR formation from glutamate or deoxyuridine. TEAR 
formation from glutamate {Figure-2) was linear as a function of 
time upto 2 h 30 min. and directly proportional to the 
concentration of ALA (0.2-1.0 mM) though the TEAR formation from 
deoxyuridine was more than two fold in comparison to glutamate 
as a target molecule (Figure-3). Similarly TEAR formation from 
glutamate increased linearly with the increase in concentration 
of copper (2 0-160 uM) and that from deoxyuridine with 2 uM to 16 
uM of copper (Figure-4 A and 4 B). 
Oxygen consumption in the reaction mixture was not noticed 
in the absence of copper. However, addition of copper resulted 
in the consumption of oxygen and increase in oxygen consumption 
v/as observed with the increase in ALA concentration (Figure 5) . 
Generation of formaldehyde from dimethyl sulfoxide during 
autooxidation of ALA was observed which was directly 
proportional to the initial concentration and rate of 
utilization of ALA (Table-9). 
Inhibition of TEAR formation from glutamate or 
deoxyuridine was observed in the presence of oxyradical 
scavengers. Presence of thiourea, mannitol or catalase inhibited 
TEAR formation from glutamate or deoxyuridine in the range of 22 
to 99%. However, inhibition by benzoate, albumin or superoxide 
45 
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120 150 
Fig, 
Time (min) 
Linearity of TBAR formation from glutamate as a 
function of time. The reaction mixture (total 
volume 1.2 ml) contained 0.033 mM of sodium 
phosphate buffer in 0.15 M NaCl (pH 7.4), 4.0 
mM glutamate and 1.0 mM ALA. The reaction was 
initiated by the addition of 0.16 mM copper ion. 
For details see Materials and Methods. The 
means of at least two experiments are shown 
with variation of 10% or less of the average. 
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Fig. 3 
0.2 O.A 0.6 0.8 1.0 
ALA(mM) 
ALA concentration-dependent increase of 
TEAR formation from glutamate ( • • ) and 
deoxyuridine (0 0) . The reaction mixture 
(total volume 1.2 ml) contained 0.033 mM of 
soidum phosphate buffer in 0.15 M NaCl (pH 
7.4), 4.0 nM glutamate or 3.2 mM 
deoxyuridine and 0.2-1.0 mM ALA. The 
reaction was initiated by the addition of 
0.16 mM copper ion. For details see 
Materials and Methods. The means of at 
least two experiments are shown with 
variation of 10% or less of the average. 
0.0^ 0.08 0.12 0.16 
Cu^^CmM) 
Fig. 4 A : Copper ion concentration-dependent 
increase of TEAR formation from 
glutamate. The reaction mixture (total 
volume 1.2 ml) contained 0.033 mM of 
sodium phosphate buffer in 0.15 M NaCl 
(pH 7.4), 4.0 mM glutamate and 1.0 mM 
ALA. The reaction was initiated by the 
addition of 0.04-0.16 mM copper. For 
details see Materials and Methods. The 
means of at least two experiments are 
shown with variation of 10% or less of 
the average. 
Cu2'*"( juM) 
Fig. 4 B Copper ion 
increase of 
deoxyuridine. 
(total volume 
concent rat ion-dependent 
TBAR fromation from 
The reaction mixture 
1.2 ml) contained 0.033 mM 
of sodium phosphate buffer in 0.15 M NaCl 
(pH 7.4), 3.2 mM deoxyuridine and 1.0 mM 
ALA. The reaction was initiated by the 
addition of 4-16 uM. For details see 
Materials and Methods. The means of at 
least two experiments are shown with 
variation of 10% or less of the averaoie. 
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Fig. 5 : Oxygen consumption with respect to increase 
concentration of ALA. The reaction mixture 
containini? 0.033 mM of phosphate buffer in 
0.15 U NaCl (pH 7.4), 4.0 mM glutamate and 
0.5 mM ALA{A) or 1.0 mM ALA (B). The 
reaction was initiated by the addition of 
0.16 mM copper ion. The means of at least 
two experiments are shown in variation of 
10% or less of the average. 
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Table-10 
Release of TEAR from glutamate or deoxyuridine during autooxidation 
of ALA in the presence of copper and the inhibition by oxygen 
radical scavengez"S. 
Experimental conditions as described in Materials and Methods 
nmoles TEAR formed after 2 hr incu-
bation at 37°C^ 
Components 
Complete reaction 
mixture 
Urea (5 mM)*^ 
Thiourea 
Mannitol 
Benzoate 
Albumin 
Superoxide 
dismutase 
Catalase 
(5 mM) 
(50 mM) 
(50 mM) 
(100 >ig/ml) 
(100 Mg/ml) 
(100 |ig/ml) 
Glutamate 
2.15 
2.26 
0.24 
0.53 
1.03 
1.08 
0.37 
0.03 
(89)^ 
(75) 
(52) 
(50) 
(83) 
(99) 
Deoxyu: 
4.04 
3.93 
0.15 
1.56 
3.84 
3.63 
3.98 
3.16 
ridine 
(99) 
(61) 
(5) 
(10) 
(1) 
(22) 
^ All values are average of two sets of experiments conducted in 
duplicate with variations of 10% or less of the average. 
Concentrations used are 0.033 mM sodium phosphate buffer in 
0.15 M NaCl (pH 7.4), 4.0 mM glutamate or 3.2 mM deoxyuridine, 
1.0 mM ALA and the reaction was initiated by the addition of 0.16 
mM copper ion. 
'^ Concentrations given in parentheses are those prior to the 
initiation of the reaction with copper. 
Numbers in parentheses are percent inhibition. 
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dismutaae were s u b s t a n t i a l l y h ighe r (50 t o 83%) with 
deoxyuridine. Urea was r e l a t i v e l y ine f fec t ive to i n h i b i t TEAR 
fonnr^iion from both the ta rge t moleaules (Tab]e = 10). 
Discussion 
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Benzene exposure has been shown to generate organic free 
radicals and superoxide radical and it is generally accepted 
that benzene requires metabolism to express its toxicity 
(Subrahmanyan et al., 1991b). Polyphenolic metabolites of 
benzene viz., hydroquinone and 1,2,4-benzenetriol have been 
shown to be toxic and the suggested mechanism includes free 
radical formation via superoxide during their autooxidation and 
the covalent binding of semiquinones to DNA, RNA and other 
cellular macromolecules (Wick, 1980; Rushmore et ai. , 1984). In 
addition, the active oxygen radical formed during autooxidation 
of polyphenolic metabolites has been shown to be involved in the 
cytotoxic effects of benzene (Irons, 1985; Karam and Simic, 
1989). Aerobic cells are equipped with an array of antioxidant 
defences such as uric acid, albumin, cC -tocopherol, ascorbic 
acid, free -SH groups, ceruloplasmin, catalase and ferroxidase 
activity which terminate the propagation of damage by free 
radicals (Halliwell and Gutteridge, 1990) . 
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Uric acid has been shown to be a selective antioxidant, 
capable especially of reaction with hydroxyl radicals and 
hypochlorous acid and also prevents oxidative inactivation of 
endothelial enzymes, cyclooxygenase and angiotensin converting 
enzyme (Becker, 1993). Uric acid can act as an antioxidant both 
by binding iron and copper ions in forms that do not accelerate 
free radical reactions, and by directly scavenging such as 
singlet oxygen and peroxyl radicals (Ames et al., 1981). The 
decrease in uric acid levels in serum of benzene exposed animals 
may be due to scavenging action on oxyradicals generated during 
benzene exposure. Howell and Wyngaarden (1960) showed that 
methemoglobin or hematin in the presence of hydrogen peroxide 
oxidized uric acid to allantoin, the initial step being a one-
electron oxidation of urate radical by a heme peroxide compound. 
The consistent decrease in uric acid level in serum of benzene 
exposed animals may be due to its rapid degradation by the free 
radicals generated during the redox reactions of polyphenolic 
metabolites of benzene. Low levels of uric acid may lead to 
toxicity implications as physiological concentration of uric 
acid has been shown to reduce oxo-heme oxidant, protect 
erythrocytes from peroxidative damage leading to lysis and also 
prevent oxidation of metmyoglobin by H2O2 (Arduini et al., 199 
Serum albumin acts as an antioxidant through binding free 
Cu "*" ions and site directs any radical damage onto albumin 
molecule itself (Halliwell and Gutteridge, 1990) . Significant 
decrease in serum albumin level of benzene treated rats may be 
due to self degradation of oxidant-damaged albumin and may have 
toxicological implications. 
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Protein sulphahydryl groups have also been suggested to 
contribute significantly to the antioxidant capacity of plasma 
(Wayner et al., 1987), although their oxidation could also be 
considered as oxidative damage, depending on the protein 
,iLJ (nM-ini. The cl<M.oxicjation of certain free radical met ab(jJ 1 ton 
was shovm to be due to interaction of xenobiotic derived free 
radicals with glutathione forming thiyl radical (GS*) (Ross, 
1988; Wardman, 1988). The decrease in liver free -SH contents 
in benzene treated rats is due to glutathione depletion through 
oxidation of free radicals. cC -Tocopherol and ascorbic acid 
are widely recognized as naturally occuring antioxidants in 
biological systems. It has been hypothesized that oC-tocopherol 
and ascorbic acid work synergistically to protect lipids from 
peroxidation. oC -Tocopherol is an important lipid soluble 
antioxidant and it breaks chains by trapping peroxyl and 
alkyoxyl radical. The tocopherol radicals formed during the 
biological processes are quenched and cC-tocopherols are 
regenerated through interaction with ascorbic acid, this water 
soluble ascorbate can act to spare depletion of membrane oC -
tocopherol levels ( Hartman and Shankel, 1990) . Moreover in 
certain conditions the ascorbate radical can itself be 
enzymatically reduced back to ascorbic acid by a NADH-dependent 
system. There was no change in serum and liver oC-tocopherol and 
liver ascorbic acid concentration in benzene exposed rats where 
as several fold increase in rate of lipid peroxidation was 
observed. This may be due to depletion of liver free -SH 
contents in benzene exposed rats. The protective role of 
catalase as an antioxidant also did not show any significant 
57 
change in liver of benzene exposed rats which catalyse the 
conversion of hydrogen peroxide into water and oxygen. 
Ceruloplasmin (EC 1.16.3.1) is an acute phase protein that 
function as an antioxidant in biological system. The 
antioxidant role of ceruloplasmin is thought to be due to its 
forroxidase activity and has been shown to inhibit iron-
catalyzed lipid peroxidation, DNA damage and cellular protein 
degradation (Gutteridge, 1991; Krsek-Staples and Webster, 1993). 
The protection by ceruloplasmin during oxidative stress is 
probably due to the oxidation of Fe II to Fe III and subsequent 
prevention of the redox cycles necessary for hydroxyl or iron 
radical formation; but no significant difference in 
ceruloplasmin concentration in serum was observed in benzene 
exposed rats compared to the respective controls. 
Transferrin, an iron binding protein, transports iron in 
the plasma. Iron bound to transferrin will not participate in 
hydroxyl radical formation or lipid peroxidation (Aruoma and 
Halliwell, 1987). In iron overload, serum iron concentration 
increased with linear increase in transferrin saturated with 
iron (Nielson et al., 1993). In benzene exposed rats (i.p. and 
s.c.) no change in transferrin saturation, serum iron as well as 
total iron binding capacity was observed, whereas significant 
decrease in ferroxidase activity indicated decline in 
antioxidant capacity of the serum to protect the radical 
mediated peroxidation of biomolecules. The primary antioxidants 
of normal plasma are concerned with limiting the reactivity of 
iron (Gutteridge and Quinlan, 1993). '^^ i^ ^^ ^^ '^ °^"^ A.:; 
'' ^ 
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Despite the large sex variations and route of exposure 
observed in the biotransformation of xenobiotics by rats, 
present studies revealed oxidant depletion in all the groups of 
rats almost similarly (Sipes and Gandolfi, 1991) . The decrease 
in antioxidant potentials in serum may allow oxygen 
intermediates such as superoxide and hydrogen peroxide to 
survive in plasma long enough. The significant decrease in uric 
acid level in the present study may be of epidemiological 
importance for clinical study in workers occupationally exposed 
to benzene. Further studies are required to relate uric acid 
levels in response to benzene exposure. 
Trace amount of metal ions are present in biological 
system. An estimated one third of all enzymes require a metal 
ion in one or more phases for their catalytic activity. 
Transition metal ions, most notably iron and copper can 
facilitate the transfer of electrons to biological 
macromolecules such as lipid, protein and DNA. In addition to 
their biological function, metal ions are responsible for tissue 
damage. Previous studies have suggested the involvement of iron 
or copper in benzene metabolite-induced DNA damage through a 
mechanism involving the generation of reactive oxygen species 
(Kawanishi et al., 1989; Rao and Pandya, 1989). In the presence 
oi trace metal ions the mutagenicity of polyphenolic metabolites 
of benzene showed an increase to the tester strain Salmonella 
tvphimurium (Lee and Lin, 1994). Recently Krsek-Staples and 
Webster (1993) observed the iron-catalyzed oxygen resulting in 
the formation of carbonyl derivatives with concomitant loss of 
enzyme function. 
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It is suggested that the elevated level of low molecular 
weight iron in the bone marrow during benzene toxicity may lead 
to formation of tissue damaging species like lipid peroxide 
radicals, superoxide anion (02~'), oxyferryl species, hydroxyl 
radicals ('OH) which may form reactive metabolite(s) and may 
react immediately if they occur in the vicinity of vital 
molecules like nucleic acids (Lown and Sim, 1977) and polymerase 
enzymes (Rushmore et al., 1984) which may be responsible for the 
ultimate cytotoxicity. During in vitro study Rao and Pandya 
(1989) obeorvod that polyphenolic metaboliteB of bonzenn a m 
autooxidized faster in the presence of copper ions and resulting 
in the formation of TEAR from target molecule such as glutamate 
and DNA. The suggested mechanism includes free radical 
formation via superoxide and the covalently binding of the 
semiquinone metabolites of polyphenols to such molecules. 
Significant increase in metal ions in liver and liver nuclei 
during benzene exposure may have toxicological implications for 
cytotoxicity of liver cells and liver nuclear DNA damage in 
vivo. 
In mammalian cells, g -aminolevulinic acid (ALA) 
synthesized from glycine and succinyl CoA by ALA synthase in the 
mitochondrial matrix, diffuses to the cytosol where it initiates 
the pathway of porphyrin biosynthesis (Kappas et al., 1983). 
Enhanced porphyrin synthesis and elevated urinary excretion of 
ALA are usually associated with congenital erythropoietic 
porphyria, intermittent acute porphyria and variegate porphyria 
(Muller-Eberhard and Vincent, 1985). Biologically available 
excess ALA, the first precursor of heme biosynthesis, has been 
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shown to cross the blood-brain barrier (McGillion et al. , 1974) 
and accumulate in brain (McGillion et al., 1975). Xenobiotic 
compounds including drugs and chemicals have been shown to alter 
porphyrin metabolism with the accumulation of heme precursors. 
ALA dehydratase, a cytosolic enzyme catalyzes the condensation 
of two molecules of ALA to form the mono-porphobilinogen (PBG), 
is inhibited by industrial pollutants such as lead (Monteiro et 
al., 1991), benzene (Rao and Pandya, 1980),. trichloroethylene 
(Fujita et al., 1984) and hexachlorobenzene (Elder, 1978) to 
result in ALA accumulation and its loss in urine. It was 
reported earlier that the decrease in hepatic ALA dehydratase 
activity in female albino rats 3 h or 20 h after exposure to 
benzene and suggested that an aromatic hydrocarbon epoxide may 
react with the nucleophilic sulphahydryl groups of ALA 
dehydratase (Rao and Pandya, 1980). Earlier Khan and Muzyka 
(1973) reported increased levels of ALA, porphobilinogen and 
protoporphyrin III in selected areas of rabbit brain following 
chronic exposure to benzene and a significant rise of 
erythrocyte ALA in industrial workers exposed to benzene. In 
patients with intermittent acute porphyria and lead poisoning 
where ALA accumulates, the erythrocytic activities of superoxide 
dismutase and glutathione peroxidase are reported to be 
increased and free radicals may be involved in the 
symptomatology of neurological porphyrias and lead poisoning 
(Monteiro et al., 1991). Bechara and Co-workers postulated that 
ALA, being a source of reactive oxygen species (ROS) by metal 
catalyzed aerobic oxidation in vitro (Monteiro et al., 1989) and 
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overproduced during acute intermittent porphyria (AlP) anc 
hereditary tyrosinemia, (Hindmarsh, 1986; Fergusson, 1990). Ii 
fact, ALA has been shown to induce lipid peroxidation and th« 
release of encapsulated carboxyfluorescein from cardiolipin ricl 
liposomes (Oteiza and Bechara, 1993), to induce single-stranc 
breaks in plasmid pBR 322 DNA (Onuki at al., 1994), to caus( 
iron catalyzed calcium dependent oxidative damage to the inne-
membrane of rat liver mitochondria (Hermes-Lima et al., 1992) 
]t was observed that the plasma levels of ALA may attain uptc 
100 fold higher in lead exposed ( >30 jig Pb/lOO gm blood] 
individuals and symptomatic AIP patients than in norma] 
individuals (Minder, 1986) and that, at least in the case oJ 
rats, the liver concentrates ALA six times with respect tc 
plasma (McGillion et al., 1975). Besides the plasma and liver, 
ALA can also accumulate in heart, kidney, spleen, gut and fat 
tissues (McGillion et al., 1975). In addition, ALA can cross 
the blood- brain barrier and concentrates intraneuronally, 
although its levels in cerebrospinal fluid are much more lowei 
than those in plasma of porphyria patients in acute crisis. The 
accumulation of ALA in nervous tissue has also been proposed anc 
is probably responsible for the neurotoxicity observed ir 
neurological porphyrias and lead poisoning. ALA has been showr 
to undergo autooxidation at very high concentrations (6 mM) anc 
this reaction is accelerated by the addition of oxyhemoglobir 
and other iron complexes (Monteiro et al., 1989). 
Copper ion concentration dependent oxygen uptake anc 
disappearance of ALA during autooxidation of ALA (1.0 mM) 
further corroborates that ALA autooxidation is associated witl: 
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the formation of active oxygen radicals. Earlier studies have 
nhowp. that ALA uudorgoea enolization boforo conauming the 
oxygen. A presemiquinoid nature of ALA has been reported 
(Monteiro et al., 1989) because at physiological pH it undergoes 
a Keto-enol tautomerism and subsequent autooxidation product has 
the same reactivity as a semiquinone which can reduce oxygen to 
superoxide anion or reduces cytochrome C via superoxide 
(Monteiro et al., 1989). 
Based on the present study it is proposed that the 
interaction of copper ions with the amino group of ALA and 
catalyse the oxidation of ALA. During this interaction cupric 
ion forms a complex with ALA, which donates an electron reducing 
it to the cuprous state. Molecular oxygen oxidizes the cuprous 
ion to cupric ion with the formation of superoxide radical which 
reduces metal ion as well as dismutates to form hydrogen 
peroxide. Hydrogen peroxide could then interact with the 
reduced copper to form a very reactive hydroxyl radical which 
can attack glutamate or deoxyuridine to release TEAR products. 
The release of TEAR products from glutamate or deoxyuridine by 
ALA in the presence of copper ion suggests that ALA was acting 
through the metal-catalyzed Haber-Weiss reaction in which 
hydroxyl radicals are produced from hydrogen peroxide. The 
presence of hydroxyl radicals in this system is also evident 
from the formation of formaldehyde from dimethyl sulfoxide. The 
two fold higher release of TEAR from deoxyuridine in comparison 
to glutamate may be due to synergism among ALA, deoxyuridine and 
oxygen free radicals as shown between bromodeoxyuridine and 
paraquat (a superoxide-generating compound), to amplify free 
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radica] mediated UNA damage (Foot et al., 1989). This may 
px-obably be the reason why oxyradical scavengers like benzoate, 
albumin, superoxide dismutase and catalase were much less 
effective in inhibiting deoxyuridine significantly as compared 
to TEAR formation from glutamate. 
Our observations indicate that ALA at physiological pH and 
in the presence of copper can generate significant amounts of 
reduced oxygen species. Cerebrospinal fluid taken from patients 
v/ith neurological disorders contained micromolar concentrations 
of loosely bound copper (Gutteridge, 1984) . Copper bound to 
proteins in the biological milieu may also support this 
autooxidation as it has been shown that copper containing enzyme 
tyrosinase catalyse oxidation reaction (Wick and Fitzgerald, 
1981). Kadiiska et al., (1993) and Kohen and Chevion (1985) 
provided electron spin resonance spin-trapping evidence for the 
synergistic generation of free radicals in vivo including the 
hydroxyl radical, during copper-mediated paraquat toxicity. 
Amplification of doxorubicin mutagenicity by cupric ion had 
provided experimental evidence that anthracycline - metal ion-
DNA associations probably contribute to genotoxicity (Yourtee et 
al., 1992). Intracellular concentrations of ALA capable of 
releasing at least some of the iron (another predominant in vivo 
transition metal capable of autooxidation and release of oxygen 
radicals) embedded in the endoplasmic reticulum has been 
suggested based on the observation that about 0.4 mM ALA can 
release Fe(ll) fxom microsomes (Minotti, 1992). The present 
observation may therefore help in improved understanding of the 
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p o s s i b l e mechanism of porphyr inpa thy and in v ivo t o x i c i t y 
m a n i f e s t a t i o n of ALA, i f the a p p r o p r i a t e p resence and 
in t e rac t ion of su i t ab le t r a n s i t i o n metal ion i s made ava i lab le 
in tho liioloqical mil iau. 
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Antioxidant potential in serum and liver of albino rats exposed to benzene 
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Administration ofbcnzcnc (ip, 0 5 ml/kg body wt or sc, I ml/kg body wt) consecutively for 10 days to male 
and fLMi lie r its resulted in decrease in antioxidant potentials in serum Scnim line acid and albumin showed 
Mj;iiilii ml (ILLIL ISL m ill groups exposed tolKii/tne a-1 ocoplicrol levels did iiotcxliihit siniiilicantcli iiige 
in ui) ol tilt groups H lien Lompartd to control Intrcascin liver lipid peroxidation and decrease in content ol 
free sulphahydrjl group were observed in rats exposed to benzene Scrum ferroxidasc activity, total iron 
eoiiiL!il(l lC).ind tot.il iron binding cap icily (TIBC) in Tcmalc rats exposed to benzene showed signifitani 
iktre iseiii lerroxid iseaelivity wilhoutanyeli.mgcin IlCor I lUC wlieneoiiipareil toeontrol 1 lie decrease in 
.intioxid lilt poteiiti lis observed may be due to oxidation reaction exhibited by benzene metabolites, parli-
eul 11 Iv liydriH|umone and I, 2, 4 ben/enetriol, resulting in oxidative stiCbs in ticiilcd iiits 
Ol cupaiioii.ii exposure to bcii/cnc lias been associ.v-
tcii with V,I nous biooclclyscrasia and.i variety of leu-
kemia in hiirnan' ^ Bcn/cnc requires mclabolism to 
express ils (oxit efTccIs Ikn/cnc is primarily nictabol-
i7ccl to phenol, liyclroqumonc, catechol and I, 2, 
4-l)cn7eiiclfio! Recent sludics involve (lie polyplic-
iiohc mclaluililcs as tlic loxic iiKcrmcdiatcs due to 
lliLii ca()il)ilily lo tiiidtfgo auto oxidation^ Hone 
iiiariowcoiilams several (leroxidascsand tlicpcroxi-
d ilic mcl iholism of the benzene metabolites results 
Id llie /onit.ilioii ol seiiiic|uiii()iie Irtc r.idicals and 
oxygen atlivatioii to SII|KIOXRIC radicals'* Semiquin-
oiic .iiid(| III none radicals lorincd during.luto-oxida-
tioiiori'iclabolisinorp(>l)()licnolscan bind lo macro 
molecules such as protems, RNA and UNA' * For-
mation ol scmiquinonc and ox)gen Irce radicals in 
bcn/cne exposed rats m ly lead to oxidative stress re-
sulting 111 ilicred lion mct.ibolism which has been 
sliown dm mg benzene exposure' " Iron is released 
Il om iron stores under eoiidilions in which oxidative 
stress is involved'" Semicjuiiione radical of adriainy-
cm has bee n sliown to iiiobiii/c and results in reduc-
tive rcic isc ofiroii Irom Icrritin" Accumulation of 
low molecular weight iron and spontaneous genera-
tion ofox)! KIK lis by bone marrow cells ofrats expo-
sed to lien/eiie iMsbeeil re polled" I he low niolccu-
I ir weight iron is generally considered as decomparl-
mentali/cd iron in contrast with iron bound lo pro-
tein, ind IS citalytically active in miliating free radical 
II t e l l o i i s ilul l ipid pi l o x i d l l i o l l ' ' '* 
* ( o i i L s p d i i i k i i l I I I I I K I I 
Generation of free radical imposes depletion of anti-
oxidants 7 he aim of the present study is to evaluate 
antioxidant potentials in serum and liver ofrats expo-
sed to benzene 
Materials and IVlctiiads 
All chemicals used were obtained cillicr from Sig-
ma Company, St Lotus, USA, or from (il.ixo Libor-
atories, India (ANLAR) 
SWISS VVistar strain albino rat,s ol either sex weigh-
ing 100-110 g, bicd at the animal house unit of flic 
Centje(l I RC), wercdividcd mlo6gioups(3groups 
of male and 3 groups of female), of 6 animals each 
One group from each sex served as control One group 
from each sex received benzene (0 5 ml/kg body wt, 
ip)and another group (roni each sex received benzene 
(I ml/kg body wt.sc)daily for lOdays Alter the termi-
nation of the treatment, blood w.is collected m non -
hcp.irmed tubes from jugular vein and kept at 4°C 
Control and experimental rats weic sacrificed by cer-
vical dislocation and liver and brain were immedia-
tely excised and a 10% honiogcnatcwasmadeinO 15 
M KCI to study lipid peroxid.ilion Liver liomoge-
natc (10% w/v) was made in 0 02 M LDIA lor the 
estimation of free sulphahydryl content Brain ho-
iiU)geiiatc(2yn w/v) was made 111 0 ISA/K( I as lipid 
source to study seiuiii lerroxidase activity 
Liver and scrum a tocopherol were estimated" 
Serum uric acid'* and albumin''' were estimated us-
ing the sl.indaid pi OK dims I eiioxid ise'" adivily 
ol ihr scf iiiii WHS UK isiir* d in Ihf lol il f( ,\( tiati vo 
lumcol4iiil which colli iincd 5mlol 2'/o biainhoiiio-
MM INDIAN J I X r i U O l MAI«( I I I'I'M 
)H n III (\\ \ t ( M ' n i l o l l i I i i ' i i ' i i l p l i I d S d l i i l m i i (11 
(•I VI I llll ll U M I U III! I l K l l l o l ' ( ) | l M I c ' ' .111(10 I m l (ll 
M.I1I111 ,111(1 w . i x i m i i b i k i l 1(11 M) n u n . it "^TC l i i c 
l I lKl l l II h l h l l K . K i d 11 K . l l \ ( p K u l l K l s \\(.'IC C s l l l l l -
.!((.(I I n I IK I I K I I U H I d l I k i i i l K i n i < / <;/ ' " 1 i \ c i l i i i i d 
|KI(I \KI ilum' ' 111(1 liLCsulpli.iliy(li>r" wcicc^tmi.i-
Icd iiiimcdi.ilcly Scrum iron binding cip.itily and 
idi ll null ut iccsliiii.iU'd iiMii)-' iMiluiphcniiiillitoline 
nil i inu K id '' 
RtMlllS 
i^csulls .lie presented in lables 1 .ind 2 
Scrum uriL .icid level signilicintly decreased and 
the m.iximimi dctrc.ise ("i?"/,) w.is m m.ilcs which re-
ceived bLii/cne ip(I.ible I) .Serum.illniminconccnt-
i.ilion ,ils(i(ki.ic.i(.d III in.ik .iiid km.lie I.IISCX|H)SCII 
to Kn/ciK lliccxtciil ol (kcie.iscu.ismoicin Icinalc 
Ml' 111.in 111 m.ile r.il*. 
i reesiilpli.ili\drvkoiitLiit ol liver showed signid-
(,iiil(ktKMsc(/ ' ' (Ml'iiiiliiiiilc, / ' - (MM III III,lie)III 
the jzMHi|)s wlnih a ie ivdl IKII/CIU' ip( I .iblc I) lldw 
ever, the jjioiips winch Kceived lK-ii/eiie s(. did mit 
show .my sif;nili(..iiil decit.ise K.ilcol lipid pctoxkl.i-
lion showed m.iiketl iiRie.isc(2 4 lold) in .ill e\peii-
menl.il gioiips when tomp.iied to respi,clive control 
group a-Tocophcrol levels in scrum and liver did not 
•ihow any chiiiifjc in iiiiy v\\w\ IIIUMIIIII (M oiip in i oni-
|i.iiison loionl iol I'loiipol i.ils(mipnbli ,li(d d.il.l) 
Larlicr studies related lo.illci.ilions iii iioii mcl.i-
bolism and benzene cxposuie were dune only in lem-
ale rats In that context, fcrroxidasc activity .\m\ iron 
bindmgcapacity were studied in only (cmalcrats The 
protection oHcrcd by scrum w.is less ng.iinsi I c^ ^  c.il.i-
lyscd lipid pcioxid.ilion ol biain liomogcn.ilc tli.in 
the sciiiin [loiii llic coiidol gioiip ol .iiiim.ils ( I ,iblc 
2) .Scrum iron conccntr.ilion ,iiul lol.il iion binding 
t.ip.icity did not show .my sigmliL.iiit CII.IIIJ'L m benz-
ene exposed .mini.lis with icsjicct to conliol group 
I ihic I I (Id I ol bcii/<nc.ulii\inis(r ilKH! on .^(.riiin concenlr.ition of .inlioxid.inC free - S H group .indst ile o( lipid pcroxid.ilioii 
in Mis 
jV ilins lit im in I SI v( (\ i iK I i( IIKS MI p iiiiillicsci .irc ptrtcnl iiitii ist ( + ) or (ILLK ISL ( ) over Lonlrolj 
l',ir,inKl(r I cm lie M.ile 
( oiilni) 
Urn .icul (III) (II) M)') I 0 M 
ip SC 
I'WMMK'' 2 4 4 1 0 i r 
( - 1 6 ) ( - 2 1 ) 
Alininiiii (cAli) 4 87 + 0 19 4 11 + 0 14'' 3 88 + 0 15*' 
( - M ) ( - 2 0 ) 
I K . SII minip ( " O i O I ' l 4 0(i±O24'' 4 6 6 ± 0 27'''' 
(|ini(ik/)Mi\ti) ( 11) ( - 0 1 ) 
I IJMI p, IOXMIIIIUII 2 11 Ml 1'. 1 11 | l I')'' 4 01 M>'1 ' 
|iiiiiM</hi/l I x d l I I I III) ( I M) 
/' vi l lus II III ' II OS '•* Ni'l Mtiiilii ml 
( (inlrol 
5 0 7 1 0 18 
3 9 1 + 0 15 
3 54 + 0 16 
2 P 10 11 
2 4 5 1 0 18' 
t - 5 2 ) 
3 51 + 0 09^ 
( - 1 1 ) 
' 2 5 4 1 0 19' 
( -2K) 
9 10 I I 5 1 ' 
( t mil) 
1 1 1 1 0 12' 
( 18) 
1 7 2 + 0 20''' ' 
( - 0 5 ) 
144 + 0 22'''' 
( - 0 ! ) 
5 01 i 1171" 
( I I I'll 
I il<l( '' Mlttl of bciuciK uliMimsu Uion on si rum fcrroxul isc .itlivily ind iron hindin)'cip icily m k m il( i iK 
[V.ilucs arc m c . i n l S l ] 
Ass.iy I crroxid.ise Iron binding c.ip.icily 
.iclivily* 
(iiinoles MDA) Sci i i in I c 
Oip/dl) 
l l l k t 
(lig/dl) 
I 111 iiiilu.Mu.jdi.ik H e ' ' 0 I iiiUtrum 17 l l 0 7X(n = 6) tonlrol 177111 ( n - 4 ) 9 S 2 1 125 (n 4) 
of control r.il'i 
II |li.,ii, l i o n o K n i k N f ' ' Mi l ml 1 M | 0 SH'(n-^i) ip (•«|io«<'(l 16^ M I ( i i - f i ) KI9 | V ) ( „ - ( . ) 
<.c/iim ol ip < xiiosrd i.ih (16 7%) 
III Br.iin homogcnalc l - t c ^ * + 0 I ml 42 4 +1 5'*'(n = 5) sc exposed 192 + 3 8 (n = 4) 9 0 3 ± 5 8 (n = 4) 
scrum of sc exposed rals (14 i%) 
II ~ number o f r its 
V.ilucs in pircnl)icsc<; arc percent incrcisc 
/•values "<0(H1|, *'<0 02 
*l 'pi riiiii Ml ll (ll I Ilk ire pncn m M.ilcri.ik and Mclliods scclion 
t I ol ll null hiiiiliii|> ( ip II il> 
I I I III ill i n n l i on s i l i i i i i l ioi i 
l i s t 
t%) 
18 6 
211} 
21 3 
AHMAD <•/«/ ANIIOXIDANI I>01LNIIALINSLRUM&UVIR0I RAIS 2(15 
11 iiiskrim iron s.itur.ilKMi m btn/ciic exposed rats 
sliowLtl \ lilies toinp ir.ibic wilh the control group 
OlStllSSKIII 
Ikii/ciK (.\posuiL h.is Ixcii shown to generate or-
j ; line IK I I UIIL.IIS.IIKI superoxide raclit.il.iiui isgenc-
lally aeecpled lli.il beii/eiie requires metabolism to 
i\pi(.ss lis io\ieil>' i'olvphenolic nielabolils of 
IKII /UU \\/ JisdioiiiiiMoiiL'and I, "* 4 ben/enelriol 
liavt Ixi iisliouii loix loKH and the suggested metlia-
nisni iiH liidi s l uc radital loim ilion via superoxide 
diainf lliui auto oxid ilion and tlieeov.ileiit binding 
ai seinii[inn(Hic's (o DNA KNA aiul olliei Lclltil.ir 
111 leioinoKeuies'- ' ' ' In addition the active oxygen 
r idieai lot incd during auto oxidation ofpolyphcno-
lic metabohles have been sliou n to be involved m the 
eviolOKK UKttsol IK n/i iic ' ' '^ Aeiobie tells.iicc(|-
uijipid Willi m a n ly ol aiilioxid ml deleikessutli as 
uiicaeid ilbumm a toeopherol, fiee - SH groups 
and/crroxidaseactivil) aliieh terminate the propa-
gation ol damage by frtc ladicals" 
IJrieaeid h is been shown to be a seleetive antioxi-
dant, capable especially ol reaction with liydroxyl 
radicals .md h) pochlorous acid and also prevents ox-
id.itivcmaeliv.ilion olcndolhclialcn/ymescycloox-
ygcii.isc ,iiul .ingiolciisin converting cn/yme^' The 
dccic.isc in uiie .icid levels m sciiim o( bcn/cneexpo-
se danim.ilsm.iy beduetosc.i\engmgactiononoxyr-
.ulic.ils generated during bcn/cne exposure Low lev-
els ol unc atid may lead to toxicitv implications as 
pliysiolojMt il coiKLiilr ilioiis ol uric .leid h.is been 
shown to iu(iieeo\i> heme oxid.ml piotecleiytliro-
eyli gliosis Iroin lipid (leioxid.it on .indeivthrocytes 
fiom peioxidativc damage le idmg to lysis and ;ilso 
pievent oxidation ol nielmyoglobm by iliO^Cicf 28) 
Antioxid mt .leliviiy ol .ilbuinin is due to radical scav-
cngmg.icdwty wlicrcin (hcictncoxsgcn radicalsdc-
gr.ide .ilbuinm molecule itsclP'' Signilieant decrease 
m sciiim ilbiimin in bcn/enc lie ileil rats m.iy have 
loxicoloi'K il implii. ilioiis 
I'lolem siilph ihvdisl gnuips h.ue.ilso been sugge-
sled In (ooliihiile signilic.inlly to !hc .iiilioxid.mt 
t ip u il> 111 |)1 I m i ' ' ill hough I he II oxid ilion could 
.il obeeoii ideinl isoxid Uivcd.im.ige, depending on 
thcprolun .ilUcdd I hedotoxic it ion ofccrtam free 
r idical mc( iboliles was shown to be due to inlcr<ic-
tion ol \cnobiotic derived fret radicals with glutathi-
one lorminglhi)l radical (GS ) ' " • " The decrease in 
l iu r l r te S!l iToupiii h n/cnclici(cdralsisdiicIo 
glut ithioiiL (k plctioii tluoiii'h oxid.ilion oflrcc radi-
c lis Ihcie w isnoch.mgc m serum and lis e ra locop-
lurol in bt n/( lie cxp(isul i ils where is sever.il fold 
iiu u I SI 111 I ill (il lipid puoMil iiion w IS obsi I Mil 
lliism IV be due lodepleiioii ol li\c/ llcc Sll group 
m ben/ene ex|i()sctl i.ils 
1 ranslcrrm, an iron binding protein, tr.insporl the 
iron in the pl.ism.i lion boiinil to li.iiislcrriii will not 
particip.ite in Ol I radic.il rorm.ilion or lipid peroxi-
d.ilioii'^ In iron overlo.id, serum ironconcentr.ilion 
increased with line.ir mcrc.ise in tr.mslerrm s.iturated 
with i r o n " In ben7ene exfiosed i.ils (ip and sc) no 
ch.mge in Ir.insferrm s.iluralion, serum iron ,is well as 
tot.il iron biiulingc.ip.icily w.isobscived, where.is sig-
mlic.mt(let(CISCIII Itnoxid.ise.iclivKy mdlc.l(edde 
tllnelll antioxKl.inl t.ip.icily ol the stiiim to piolect 
(he radical medi.iled petoxid.ilion ol biomoleciiles 
I liepnin.iiy .mtioxid.mlsol noim.il pi,ism i ,iie conc-
erned with limiting Ihe ic.ieliviiy ol iion' ' ' 
Despite the large sex variations and loute ol expos-
ure observed in the biotranslonnation of xenobiotics by 
Mis, present studies reve.ilcd .mlioxid.ml (Itplelioii in 
all Ihegioupsol inlsiilmosl siiiiil iily " I lu dti iiase 
111 aiUioxid.ini potcnii.ils in sei iim m.iy .illovv oxygen 
intermediates such .11 superoxide .ind hydrogen per-
oxide to survive in plasma long enough 1 he signilicanl 
decrease in uric .icid level in the present sliitly m.iy be 
ofepidemiologic.il import.nice in workers oceupa-
(lonally exposed to ben/ene / urther studies arc re-
quired to rel.ite uric acid levels m response to expos-
ure to ben/ene 
Acknowledgement 
7 hanks arc due to fCMK, New/X'llii for grant iii-
did and Mr Lakshmi Kant for typographical assis-
tance 
Kcfcrcnces 
1 RinskyRA Sniill iAl) lloriuinc K l o l l o i i K , Ymiiif'RJ, 
Okun A II & I iiulier.m I'J /Vi ii /iif;l I MctI M6 (I^K?) 
1044 
2 Aksoy M liuinm lllili l\r\iHcl «2 (I9S9) 191 
1 R lo G S A I'lnily,! K P l,ixuohR\ V) (198';) V) 
4 Siibr.ihm iny im V V Rdss 1) I ISIMIDIUI I) A .^ Sniilli M I 
//<( «,/,/»,(/ Ihol M,,l l^ (IWI) 1'»S 
5 Aircllinid dr i l l s ( ol icci A M i/yullo M <St I'lodi Ci (<iiHtr 
IJIIIIH (19KS) 159 
r i j D w i l VViiikl( S K i l l ( , Wil / (p ,i& Siivacr It lliol ,H,il 
iiiHIiM mil mil i/iiid \ Vol III (I'll MIJlii I'll ss Niw Ynik) 
1986 X25 
7 [jcxl W K(K>:i'! J J 4% Siiyilir R,/(MKoZ/f/yi//Vi(jf»i(;(()/ 27 
(1974)411 
8 S n \ a s l a v i R C KlianS Sh inker U&Piiiily.i K P Anhloxt 
cnl 4 2 ( 1 9 7 9 ) 4 3 
9 Pandya K P Rao G S Kh in S &. Krisliii inuirlliy R Arch 
loxuni 64(199(1) 119 
10 I crrali M SignoiiniC ( l e t o l i l (^( oiiiiioiii M IhmlumJ 
2X5(1992) 29S 
11 Thorn is C t A A i i s l S n 'in h Bun In m Ihophy \ 21X(19«6) 
( , t l 
12 R l o d S ( IIHI S K iV I' iiuly I K P ( liti ( luin In \i>i ( iiiniti\ \ 
(I9;()) 111 
II J.icohis A nio,H> 50 (1977)411 
2( ) f ) I N D I A N J E X P B I O l . M A R C H I W 4 
II II illiu>ll H.V (.Mil. 11.1)'. I M ( , \i.l,lluH}i,,n lUoj'hw ?'l(i ?0 ll.illiwi'jl II <^  (Inllcinlcc I M ( , in It IIUHIUII, lli„iiln\.2V. 
I r i ' (.1 III ( l i ) ' ) l l ) I 
!•' I n l o i - I I 1111,1, , , M I'A l i | . | . , I M / , , . „ /> I I ( I ' l / d ) - ; ! ! ! 1? I l f i k n I I I h,i llinhial lliol M, ,1 |. | ( I ' / ' M ) f , | ' i 
III \ \ i i n l l i ' i i M > I ' Mh i,',ufiU u\ mill, ,/i, itlhiiiihiiiiiMi i (( l i i i a ' - 7X A f i l i i i i i l A , M I I I K I IK HI < i. K i id i iK i < i I ,1 ). i i iui/ i( i VV. ( I I M l i ' . l r i r i 
lu l l I..11.1.Mil I 'K.I \'IkVMknw'-V, hvr lUiiliial lliiil Mul,\\{W>7)-W> 
W D . h i . i l l ' l . n v i i H.V K iMi i c i A /1 ,ih (liii Miil.M){\^^l) 29 W i i y i i r r I ) I ) M , l l i i i l i u i (1 W , I I I K O U I K I I , l l u i c l ny L K & 
.'.'M I c i ikp S I, llliiilum llii>ithv\ Aihi, ')?') {I'»H7) -lOH 
IK ( ; M I I . - I M ( C . ' I M ( . fliii,/ii III / . ' I W I ' / K / ) 4 I < .1(1 lUm I). /%iiiiiii(i)l l/i(iiiiiy. I / ( I V K K ) ; M 
I'l I I K I I I K M I I ) . I I . I I I I K M I I M 1 ( <V W i l b i i ; K f\\..l lliuU In in. I7.( . ' I V/iin\mi)i) V, iii (iliiliilhiimr i iiii/iii;iiliiui. im i /mnn/n iiiiilhloli)-
t\')\V) ^ ' ; >;((((/\(;; i i i / /((Hi(( ' , c d i l i - d l i y I I SiL's (^ II K i ' l l c i c r (AL iu lc tn ic 
20 .Sall.ik J & I.iml'..i> R II. Aniil ilimItem 2") (l%X) 192. I'rcss, New York). I9KK, 4 i 
21 I V k i ' . I . C M O V in i i i c l lo 1 .1. A p l I A KossJ I JhihChiMal. .12 A r i i o m a ( ) I <^ l l . i l l iwc i t I I , Ihoilum J. 241 (19X7) 271 
•IS {\')M^\ 2S0 .1.1 N ic lMin ('. I J i i l l n u i i n J , W u K I i c k c l U & H c i n r i t l i M C, / m y 
? : W i t k M M . f „ / / , , / • A ' M .)(M19X(I) | . ) | " l nioihim 2 ^ ( 1 9 9 1 ) 2?1 
J l U M S I M M I M . I . '<i i>(l i ' i U .V K . I I I ( I < h, III llml litiriiii iiiiit\,'\') 14 ( Mi l l r i i ( ! ) 'o I M ( 'A t (>i iPi l . in ( i J . / / i i / i / i » ; i / / i d / i / o ( / ( r ^ / . I I "iCi 
( I ' J X l l I U ( I 9 9 n 14.1 
24 IrcMi R I ) . / l,i\n,>l I iniriiii lllilt U, ( HJK'i) f .71 15 Si ix- i U i & t i . i m l n l d A J. m/ .> \ i< O/IJJM cd ikHlhy M ( ) A m d u r . 
25 K. i i .Hi i I R * .SiiiiiL M Ci. /.Huron llhh I'rr^pc, (. 82 ( I9K9) J Oou l l & C O K l a a w n ( IV rga ino t i /'re-i>;. New Y o r k ) , 1991. 
17 KK 
